ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Molecular and Structural Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1555203

This article is part of the Research TopicLinking the Endocrine System With ImmunityView all 9 articles

Gut microbiota is involved in the exacerbation of adrenal glucocorticoid steroidogenesis in diabetic animals by activation of the TLR4 pathway

Provisionally accepted
  • 1Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil
  • 2University of Kansas, Lawrence, Kansas, United States
  • 3University of São Paulo, São Paulo, Rio Grande do Sul, Brazil

The final, formatted version of the article will be published soon.

Diabetes induces glucocorticoid production in patients and animal models, however, the exact mechanism behind this phenomenon is still elusive. The activation of toll-like receptor (TLR) 4 induces glucocorticoid production by the adrenals. Since diabetic patients showed gut dysbiosis in parallel to an increase in epithelial-intestinal permeability, this study investigates the role of TLR4 activation by gut bacteria-derived lipopolysaccharide on the overproduction of corticosterone in diabetic rodents. Diabetes induction was achieved through the intravenous injection of alloxan, followed by treatments with antibiotic therapy or TLR4 antagonist (TAK-242) for 14 consecutive days. Diabetic animals showed an increase in plasma corticosterone levels as well as overexpression of TLR4 and Toll/IL-1R domain-containing adaptor-inducing IFN-β (TRIF) in the adrenals. Diabetic mice also showed gut dysbiosis, with an increase in the relative proportion of potentially pathogenic bacteria. We observed morphological alterations as well as increased inflammation in the colon with a predominance of a Th17 cytokine profile in diabetic mice, in parallel to an increase in the epithelial-intestinal permeability and lipopolysaccharide content in the adrenals. TAK-242 significantly decreased the overexpression of adrenocorticotropic hormone receptor and 11β-hydroxysteroid dehydrogenase type 1 in the adrenal glands of diabetic mice. Furthermore, both TLR4 antagonist and TLR4 mutant mice (C3H/HeJ) induced a significant reduction in plasma corticosterone levels in diabetic mice. Our findings revealed that gut dysbiosis participates in the exacerbation of corticosterone production by diabetic animals, suggesting that therapeutic strategies that can normalize gut microbiota in diabetics represent promising therapeutic candidates for the treatment of glucocorticoid-induced comorbidities in diabetes.

Keywords: Diabetes1, gut microbiota2, HPA axis3, LPS4, glucococorticoids

Received: 03 Jan 2025; Accepted: 28 Apr 2025.

Copyright: © 2025 Magalhães, Chaves, Thomasi, Insuela, Pauer, Hardoim, Antunes, Silva, Martins and Carvalho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Vinicius Frias Carvalho, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.